레피다인

레피다인 is a biotech company in Seoul, South Korea.

Headquarters
Seoul

About

레피다인 develops cancer solutions using liquid biopsy for early detection, prognostication, and companion diagnostics. Its development work applies liquid biopsy to cancer diagnosis, encompassing detection of disease at an early stage, assessment of prognosis, and diagnostic approaches that support treatment decisions.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

레피다인 on Indexed.vc
<a href="https://indexed.vc/companies/lepidyne"><img src="https://indexed.vc/api/badge/company/lepidyne" alt="레피다인 on Indexed.vc" width="260" height="76" /></a>